学术探索
学术期刊
新闻热点
数据分析
智能评审

The natriuretic peptides in cardiovascular medicine

被引：126
作者：
Munagala, VK [1 ]
Burnett, JC [1 ]
Redfield, MM [1 ]
机构：
[1] Mayo Clin, Rochester, MN 55905 USA
来源：
CURRENT PROBLEMS IN CARDIOLOGY | 2004年 / 29卷 / 12期
关键词：
D O I：
10.1016/j.cpcardiol.2004.07.002
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Within the last five years, assay systems for measurement of plasma levels of brain natriuretic peptide (BNP) have been approved as a diagnostic aid for heart failure (HF). Similarly, nesiritide, a recombinant form of human BNP, has been approved for the treatment of acutely decompensated HE Both BNP as a diagnostic test and a therapeutic modality are rapidly becoming integrated into clinical practice. The purpose of this review is to provide a brief overview of the physiology of the natriuretic peptides relevant to their informed clinical use. The current literature regarding the utility of measuring BNP for the diagnosis and management of HF is reviewed and practical recommendations regarding the interpretation of BNP levels are offered. The clinical literature regarding the use of recombinant BNP for the treatment of HF is reviewed, underscoring current gaps in our knowledge regarding the indications for and benefits of this novel agent.
引用
收藏
页码：707 / 769
页数：63
相关论文
共 158 条
  • [21] A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: A pilot study
    Cheng, V
    Kazanagra, R
    Garcia, A
    Lenert, L
    Krishnaswamy, P
    Gardetto, N
    Clopton, P
    Maisel, A
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) : 386 - 391
  • [22] CHINKERS M, 1991, J BIOL CHEM, V266, P4088
  • [23] Chinkers M, 1996, P SOC EXP BIOL MED, V213, P105
  • [24] Effects of brain natriuretic peptide on exercise hemodynamics and neurohormones in isolated diastolic heart failure
    Clarkson, PBM
    Wheeldon, NM
    MacFadyen, RJ
    Pringle, SD
    MacDonald, TM
    [J]. CIRCULATION, 1996, 93 (11) : 2037 - 2042
  • [25] Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure.
    Colucci, WS
    Elkayam, U
    Horton, DP
    Abraham, WT
    Bourge, RC
    Johnson, AD
    Wagoner, LE
    Givertz, MM
    Liang, CS
    Neibaur, M
    Haught, WH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (04) : 246 - 253
  • [26] Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care
    Cowie, MR
    Struthers, AD
    Wood, DA
    Coats, AJS
    Thompson, SG
    PooleWilson, PA
    Sutton, GC
    [J]. LANCET, 1997, 350 (9088) : 1349 - 1353
  • [27] Short-term intravenous milrinone for acute exacerbation of chronic heart failure - A randomized controlled trial
    Cuffe, MS
    Califf, RM
    Adams, KF
    Benza, R
    Bourge, R
    Colucci, WS
    Massie, BM
    O'Connor, CM
    Pina, I
    Quigg, R
    Silver, MA
    Georghiade, M
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (12): : 1541 - 1547
  • [28] B-type natriuretic peptide limits infarct size in rat isolated hearts via KATP channel opening
    D'Souza, SP
    Yellon, DM
    Martin, C
    Schulz, R
    Heusch, G
    Onody, A
    Ferdinandy, P
    Baxter, GF
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2003, 284 (05): : H1592 - H1600
  • [29] Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting
    Dao, Q
    Krishnaswamy, P
    Kazanegra, R
    Harrison, A
    Amirnovin, R
    Lenert, L
    Clopton, P
    Alberto, J
    Hlavin, P
    Maisel, AS
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) : 379 - 385
  • [30] Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: a population based study
    Davies, MK
    Hobbs, FDR
    Davis, RC
    Kenkre, JE
    Roalfe, AK
    Hare, R
    Wosornu, D
    Lancashire, RJ
    [J]. LANCET, 2001, 358 (9280) : 439 - 444
12345678910